The Pharma Data

AUGUST 15, 2021

About TICOVAC (Tick-borne encephalitis vaccine) Pfizer’s TBE vaccine, marketed under the brand names FSME-Immun ® and TicoVac in Europe, and TICOVAC in the U.S., 7 It is able to induce neutralizing antibodies against the natural TBE virus, as the sequence and structure of the virus subtype match those found in nature.

FDA Approval 52

FDA Approval Vaccination Vaccine Containment 52

The Pharma Data

JANUARY 18, 2021

oncolytic virus (VVcopTK-RR-), and has been engineered to encode both a Treg-depleting human recombinant anti-CTLA4 antibody generated by BioInvent’s proprietary n-CoDeR®/F.I.R.S.T generated oncolytic virus candidate to enter clinical development” said Dr. Maud Brandely, MD, PhD, Chief Medical Officer of Transgene.

Trials 40

Trials Antibody Engineer Clinical Trials 40

pharmaphorum

SEPTEMBER 18, 2020

The name Zeneca was invented by a branding consultancy who had been instructed to find a name which was memorable, had no associations with other companies, nor was offensive in any language”. The profits from these products funded the development of new drugs, such as gastroesophageal treatment Losec and cardiovascular treatment Aptin.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

The Pharma Data

JANUARY 22, 2021

But while you wait your turn, there are some steps you can take to give the vaccine — whichever brand you get — a boost when it’s available to you. “What we see is that stress can delay your antibody response to the vaccine,” Kiecolt-Glaser said. FRIDAY, Jan. So, it has a lot of unpleasant consequences.”

Immune Response 52

Immune Response Vaccination Vaccine Antibody 52

The Pharma Data

NOVEMBER 23, 2020

The initial pipeline contains biosimilar candidates for treatment in the fields of autoimmunity, ophthalmology, and oncology, as well for treating severe immune and inflammatory conditions. Ltd are gaining an extremely valuable access to Yangtze River Pharmaceutical’s strong brand reputation and market experience in China.

Manufacturing 40

Manufacturing Medicine Marketing Containment 40

The Pharma Data

FEBRUARY 25, 2021

Pfizer’s TBE vaccine, marketed under the brand names TicoVac and FSME-Immun in Europe, is an inactivated whole virus vaccine developed using a master ‘seed’ virus that is similar to the TBE virus found in nature. DISCLOSURE NOTICE: The information contained in this release is as of February 23, 2021. This release contains forward?looking

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

XTalks

JANUARY 25, 2021

The injectable treatment is called Cabenuva and contains two drugs in its injectable formulation — cabotegravir, an integrase inhibitor, and rilpivirine, a second-generation non-nucleoside reverse transcriptase inhibitor. The long-acting injection can help relieve HIV patients from having to take a daily cocktail of pills.

FDA Approval 52

FDA Approval Trials Clinical Trials Clinical Trials 52

The Pharma Data

FEBRUARY 23, 2022

About TicoVac™ (Tick-borne encephalitis vaccine) Pfizer’s TBE vaccine, marketed under the brand names FSME-Immun® and TicoVac™ in Europe and TicoVac™ in the U.S., induces protective antibodies against the three most prevalent subtypes of the TBEV circulating globally. 1 In these studies, seropositivity rates were 99.5%

Vaccination 52

Vaccination Vaccine FDA Approval Production 52

The Pharma Data

DECEMBER 20, 2020

Pfizer and BioNTech announced additional data on neutralizing antibody and T-cell responses from their Phase I/II trial of their COVID-19 vaccine conducted in Germany. The trial will evaluate one or two drugs on COVID-19, currently Eli Lilly’s LY3819253 (also LY-COV555, an antibody from their collaboration with AbCellera).

Trials 52

Trials Gene Therapy Vaccination Vaccine 52

The Pharma Data

DECEMBER 13, 2020

The aplastic anemia investigational new drug application is currently filed with the FDA under the brand name CordIn®, which is the same investigational development candidate as omidubicel. Omidubicel is also being evaluated in a Phase 1/2 clinical study in patients with severe aplastic anemia (NCT03173937).

Licensing 52

Licensing Licensing Clinical Trials Clinical Trials 52

The Pharma Data

JANUARY 6, 2021

Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. Bayer Forward-Looking Statements This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. billion euros.

Vaccination 52

Vaccination Vaccine Development Production 52

The Pharma Data

APRIL 11, 2021

Patients must have relapsed after the last rituximab-, rituximab biosimilars-, or anti-CD20 monoclonal antibody (e.g., obinutuzumab)-containing therapy (other previous treatment lines after rituximab were allowed) and either had a treatment-free interval of ?12 Israel and Taiwan under the brand name Aliqopa.

HR 52

HR Trials Containment Development 52

The Pharma Data

OCTOBER 23, 2020

The Midwest and Rocky Mountains are struggling to contain major outbreaks, while new hot spots are emerging in other parts of the country. is selling the drug under the brand name Veklury. Kentucky announced more than 1,470 cases on Thursday, the biggest one-day jump ever in that state. California-based Gilead Sciences Inc.

Drugs 52

Drugs FDA Approval Doctor Doctors 52

The Pharma Data

OCTOBER 24, 2020

” The Midwest and Rocky Mountains are struggling to contain major outbreaks, while new hot spots are emerging in other parts of the country, The New York Times reported. is selling the drug under the brand name Veklury. . “We are starting this wave much higher than either of the previous waves,” she explained.

Drugs 52

Drugs FDA Approval Doctor Doctors 52

The Pharma Data

OCTOBER 26, 2020

Based on these promising findings, Transgene intends to continue the clinical development of TG4001 in a larger, controlled confirmatory study as we look to provide a better treatment option for this patient population,” added Dr. Maud Brandely, MD, PhD, Chief Medical Officer of Transgene. Commenting on this novel immunotherapy regimen, Prof.

Vaccination 40

Vaccination Vaccine Trials Containment 40

The Pharma Data

DECEMBER 21, 2020

The selective destruction of such proteins is expected to have multiple advantages over classical drugs such as inhibitors and antibodies for the development of novel therapeutics against a broad range of diseases. Sosei Heptares is headquartered in Tokyo, Japan with corporate and R&D facilities in Cambridge, UK.

Drugs 40

Drugs Protein Development Production 40

Delveinsight

AUGUST 13, 2020

It contains fluticasone furoate, an inhaled corticosteroid, umeclidinium, a long-acting muscarinic antagonist; and vilanterol, a long-acting beta2-adrenergic agonist, delivered in GSK’s Ellipta dry powder inhaler. The analyses being presented at ATS provide new insights on triple therapy and the movement towards personalized treatment.

Antibody 40

Antibody Medicine Trials Development 40

The Pharma Data

APRIL 27, 2021

due to COVID related stocking in Q1 2020 and low demand for cough and cold brands in Europe. Dupixent ® total prescriptions (TRx) increased 51% ( year-over-year ) and new-to-brand prescriptions (NBRx) grew 16% despite fewer in-person physician visits which remain below the pre-COVID level. CHC decreased 7.3% In the U.S.,

Sales 52

Sales Vaccination Vaccine Medicine 52

The Pharma Data

FEBRUARY 8, 2021

due to decreased sales of Cough & Cold related portfolio in Europe partially offset by Digestive Health brands. Dupixent ® total prescriptions (TRx) increased 65% ( year-over-year ) and new-to-brand prescriptions (NBRx) grew 18% despite fewer in-person physician visits which remain below the pre-COVID level. CHC down 3.0%

Sales 52

Sales Vaccination Vaccine Production 52

The Pharma Data

FEBRUARY 4, 2021

due to decreased sales of Cough & Cold related portfolio in Europe partially offset by Digestive Health brands. Dupixent ® total prescriptions (TRx) increased 65% ( year-over-year ) and new-to-brand prescriptions (NBRx) grew 18% despite fewer in-person physician visits which remain below the pre-COVID level. CHC down 3.0%

Sales 52

Sales Vaccination Vaccine Production 52

The Pharma Data

MAY 4, 2021

Biosimilars, which grew 79% operationally to $530 million, primarily driven by recent oncology monoclonal antibody biosimilar launches of Ruxience (rituximab), Zirabev (bevacizumab) and Trazimera (trastuzumab) globally, as well as continued growth from Retacrit (epoetin) in the U.S.;

Vaccination 40

Vaccination Vaccine Production Sales 40

The Pharma Data

JUNE 18, 2021

The BTK protein sends important signals that tell B cells to mature and produce antibodies. If you cannot afford your medication, contact genentech-access.com/patient/brands/venclexta for assistance. Concomitant use of preparations containing St. BTK signaling is needed by specific cancer cells to multiply and spread.

Medicine 52

Medicine Production FDA Approval Development 52

The Pharma Data

JUNE 18, 2021

The BTK protein sends important signals that tell B cells to mature and produce antibodies. If you cannot afford your medication, contact genentech-access.com/patient/brands/venclexta for assistance. . Concomitant use of preparations containing?St. BTK signaling is needed by specific cancer cells to multiply and spread.

Medicine 40

Medicine Production FDA Approval Development 40

The Pharma Data

AUGUST 6, 2020

for the treatment of adult patients with multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody. Regulatory. All clinical trial activities are planned to resume by the end of the year where local country restrictions have been lifted.

Production 52

Production Branding Marketing Containment 52

XTalks

SEPTEMBER 14, 2020

“Vaccine Nationalism” Could Prove the Undoing of COVID-19 Containment. For their part, Johnson & Johnson published findings at the end of July in which they reported a single dose of their vector-based vaccine induced robust neutralizing antibody responses in rhesus macaques. Johnson & Johnson’s COVID-19 Vaccine.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92